Hovione opens Ireland plant

Hovione has opened the API manufacturing site in Cork, Ireland, which it agreed to acquire from Pfizer in December 2008. Hovione will continue to perform some manufacturing for Pfizer, which has manufactured Lipitor at the site for more than 10 years. However, the facility will mostly be used to address Hovione's own production needs.
Hovione

The US Senate Finance Committee has approved Kathleen Sebelius nomination as secretary of health and human services

Wall Street Journal

Excelsyn wins Queen's Award

Excelsyn has won the Queen’s Award for Enterprise 2009, in the International Trade category, in recognition of a near-trebling of its export earnings, which now account for 82% of sales.
Daily Post

AMRI relocates Bothell, WA, R&D laboratory - new facility has space for expansion

AMRI

CIA calls for UK Government to re-skill chemical workers during recession

CIA

PharmEng to file for bankruptcy

Toronto Star

Cambrex has been notified that it no longer meets NYSE listing standards

RTT News

Angel Biotechnology has signed a £1.1m deal to manufacture antibodies with Materia Medica - its third contract with the Russian company

Reuters

BASF has completed its acquisition of Ciba

Forbes

CIA and ICC sign MoU

The Chemical Industries Association and Indian Chemical Council have signed a memorandum of understanding to encourage the development of trade between the UK and India.
CIA

DSM selected as Shire's manufacturing partner following close of Maryland plant

DSM

Cobra Biomaufacturing is in acquisition talks with a third party

Cobra

Shire closes plant outsources manufacturing

UK pharma company Shire is phase out manufacturing at its Owings Mills, MD, facility over the next three years. Shire plans to outsource the manufacturing to a North Carolina-based manufacturer as the company moves away from in-house manufacturing.
Baltimore Sun

BASF-Ciba acquisition approved by US and Chinese authorities

BASF

Piramal Healthcare relocates custom manufacturing

Piramal Healthcare has closed its API contract manufacturing facility in Huddersfield, UK. Piramal will move the manufacturing jobs to its Morpeth, UK, and Ennore and Ahmedabad, India sites. The move will cost &3163;10m but the company expects to see profits in its custom manufacturing business improve by 6-8% by 2010-11.
Business Standard

Dow Chemical completes Rohm & Haas acquisition

Wall Street Journal

Lonza’s antibody drug conjugate facility in Visp, Switzerland has received a SafeBridge “Potent Compound Safety Certification"

Lonza

SOCMA changes name

SOCMA has changed its name to the Society of Chemical Manufacturers and Affiliates. Previously known as the Synthetic Organic Chemical Manufacturers Association, SOCMA believes the change formally broadens the scope of its activity to reflect service to the batch, custom and specialty chemical industry. Following changes to its charter all categories of SOCMA membership are now available to companies involved in batch, custom and specialty rather than just synthetic organic chemical manufacturing.
Pharmaceutical Business Review

Shasun has closed its Annan, Scotland, manufacturing plant

In-Pharma Technologist

Johnson Matthey to close Irish plant

Johnson Matthey plans to close its fine chemical manufacturing facility in Ireland and consolidate manufacturing of prostaglandin products at its US facility. The company said that in the quarter to the end of March its Fine Chemicals & Catalysts Division's sales excluding precious metals were ahead of the same period last year helped by favourable exchange translation and that good sales of active pharmaceutical ingredients offset some weakness in catalysts and chemicals.
Reuters